2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells

被引:6
|
作者
Singh, Supriya [1 ]
Saxena, Anil K. [1 ]
机构
[1] Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
关键词
Hsp90 Inhibitor; Purine Derivative; Molar Refractivity; Physiochemical Parameter; Trimethoxyphenyl;
D O I
10.1007/s00044-007-9064-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The chaperone heat shock protein 90 (Hsp90) is an emerging target for designing anticancer agent due to its important roles in maintaining transformation and modulating the survival and growth potential of cancer cells. Quantitative structure-activity relationship (QSAR) studies have been carried out in a series of purine derivatives with Hsp90 inhibitory activities. The two-diemensional (2D) QSAR studies revealed that the activity is positively influenced by the presence of a halo substituent in the trimethoxyphenyl moiety and by electronic parameter (field effect) of the 9-N substituent where the contribution of the steric parameter (MR) is negative. The best QSAR model with good correlation coefficient (r(2) = 0.738), of high statistical significance (> 99.9%) well explained the variance in activity.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 50 条
  • [1] 2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells
    Supriya Singh
    Anil K. Saxena
    Medicinal Chemistry Research, 2008, 17 : 290 - 296
  • [2] Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase
    Chiosis, G
    Lucas, B
    Shtil, A
    Huezo, H
    Rosen, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) : 3555 - 3564
  • [3] Purine-Scaffold Hsp90 Inhibitors
    Taldone, Tony
    Chiosis, Gabriela
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (15) : 1436 - 1446
  • [4] Purine-scaffold Hsp90 inhibitors
    Chiosis, Gabriela
    Tao, Hui
    IDRUGS, 2006, 9 (11) : 778 - 782
  • [5] Discovery and development of purine-scaffold Hsp90 inhibitors
    Chiosis, Gabriela
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1183 - 1191
  • [6] Discovery and development of purine-scaffold Hsp90 inhibitors
    Chiosis, Gabriela
    Kang, Yanlong
    Sun, Weilin
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (01) : 99 - 114
  • [7] Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90
    Chiosis, Gabriela
    Lucas, Brian
    Huezo, Henri
    Solit, David
    Basso, Andrea
    Rosen, Neal
    CURRENT CANCER DRUG TARGETS, 2003, 3 (05) : 371 - 376
  • [8] Radiosensitization of human lung cancer cells by the novel purine-scaffold Hsp90 inhibitor, PU-H71
    Segawa, Tatsuya
    Fujii, Yoshihiro
    Tanaka, Aya
    Bando, Shin-Ichi
    Okayasu, Ryuichi
    Ohnishi, Ken
    Kubota, Nobuo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (03) : 559 - 564
  • [9] Structures of Hsp90α and Hsp90β bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity
    Huck, John D.
    Que, Nanette L. S.
    Sharma, Sahil
    Taldone, Tony
    Chiosis, Gabriela
    Gewirth, Daniel T.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2019, 87 (10) : 869 - 877
  • [10] Purine-scaffold HSP90 inhibitors: The journey from a designed lead to a clinical candidate
    Chiosis, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 18 - 18